Simon Bullock discusses his research into intracellular trafficking of RNA, and talks about the importance of science outreach in inspiring the next generation of young scientists. More…
LMB In The News
Sharp focus on Alzheimer’s may help target drugs
Abnormal deposits that build up in the brain during Alzheimer’s have been pictured in unprecedented detail in research led by Sjors Scheres and Michel Goedert. More…
G-protein coupled receptors as drug targets: Heptares Therapeutics celebrates its tenth anniversary
Chris Tate – co-founder of Heptares Therapeutics, a company established to commercialise research from the LMB – discusses his work on G-protein coupled receptors. More…
Cambridge105 coverage of the LMB Open Day
Interviews with Katja Roper, Andrew Carter and William Schafer at the LMB Open Day. More…
AstraZeneca and LMB breakthrough on how DNA is repaired
Using the pioneering technique of cryo-EM, scientists at AstraZeneca and LMB have made a ground-breaking biological discovery that could help develop new cancer treatments. More…
Building better brains: A bioengineered upgrade for organoids
Study by Madeline Lancaster and collaborators at IMBA is one of the first attempts to combine organoids with bioengineering. More…